Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
The Ceylon Medical Journal
|
December 1, 1971
Empyema thoracis
A T Paul, R Rasaretnam, A R Paul
Cancer Treatment Reports
|
October 1, 1980
Phase III study of ICRF-159 versus 5-FU in the treatment of advanced metastatic colorectal carcinoma
A R Paul, R B Catalano, P F Engstrom
Cancer Clinical Trials
|
January 1, 1978
Phase I trial of ICRF-159 in combination with 1.3 bis-(2-chloroethyl)-1-nitrosourea (MeCCNU)
A R Paul, R B Catalano, P F Engstrom
Cancer
|
February 15, 1988
Combined radiation and chemotherapy as primary management of adenocarcinoma of the esophagus and gastroesophageal junction
L R Coia, A R Paul, P F Engstrom
Hybridoma
|
July 1, 1986
Treatment of advanced measurable or evaluable pancreatic carcinoma with 17-1A murine monoclonal antibody alone or in combination with 5-fluorouracil, adriamycin and mitomycin (FAM)
A R Paul, P F Engstrom, L M Weiner, et al.
Talanta
|
April 1, 1995
A review on thiocyanate methods for the estimation of molybdenum by molecular absorption spectroscopy
A C Basak, K C Ghosh, A R Paul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1984
An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, Adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277)
H O Douglass, P T Lavin, A Goudsmit, et al.
Digestive Diseases and Sciences
|
August 1, 1992
Heterotopic mucinous cystadenoma of the pancreas
N Z Carp, A R Paul, M J Kowalyshyn, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1991
Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma
L R Coia, P F Engstrom, A R Paul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1990
Phase II study of biochemical modulation of fluorouracil by low-dose PALA in patients with colorectal cancer
P J O'Dwyer, A R Paul, J Walczak, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
The Ceylon Medical Journal
|
December 1, 1971
Empyema thoracis
A T Paul, R Rasaretnam, A R Paul
Cancer Treatment Reports
|
October 1, 1980
Phase III study of ICRF-159 versus 5-FU in the treatment of advanced metastatic colorectal carcinoma
A R Paul, R B Catalano, P F Engstrom
Cancer Clinical Trials
|
January 1, 1978
Phase I trial of ICRF-159 in combination with 1.3 bis-(2-chloroethyl)-1-nitrosourea (MeCCNU)
A R Paul, R B Catalano, P F Engstrom
Cancer
|
February 15, 1988
Combined radiation and chemotherapy as primary management of adenocarcinoma of the esophagus and gastroesophageal junction
L R Coia, A R Paul, P F Engstrom
Hybridoma
|
July 1, 1986
Treatment of advanced measurable or evaluable pancreatic carcinoma with 17-1A murine monoclonal antibody alone or in combination with 5-fluorouracil, adriamycin and mitomycin (FAM)
A R Paul, P F Engstrom, L M Weiner, et al.
Talanta
|
April 1, 1995
A review on thiocyanate methods for the estimation of molybdenum by molecular absorption spectroscopy
A C Basak, K C Ghosh, A R Paul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1984
An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, Adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277)
H O Douglass, P T Lavin, A Goudsmit, et al.
Digestive Diseases and Sciences
|
August 1, 1992
Heterotopic mucinous cystadenoma of the pancreas
N Z Carp, A R Paul, M J Kowalyshyn, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1991
Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma
L R Coia, P F Engstrom, A R Paul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1990
Phase II study of biochemical modulation of fluorouracil by low-dose PALA in patients with colorectal cancer
P J O'Dwyer, A R Paul, J Walczak, et al.
Page
of 2